2025-03-01
2024-05-19
| Summary | |
|---|---|
| Cancer Type | Lung Cancer |
| Grade | NA |
| Stage | NA |
| Ethnicity | Western |
| Gender | M |
| Age | 65 |
| Pathology Diagnosis | non-small cell lung cancer. Pathol comment: approximately 70% of the tissue involved by malignant tumor in sections examined. 5% necrosis. c/w non-small cell carcinoma. approximately 70% malignant tumor cells present in cytospin preparation. |
| Biopsy Site | Left axilla |
| Treatment History | Evastin, tarceva,navalbine,topotecan,gemzar,alimta |
| Pathology QC | Moderately to poorly differentiated adenocarcinoma with necrosis (P0, P2) |
| Special Features | NA |
| Mouse Strain | NOD SCID |
| TMA | NA |
| Viral Status in PDX | NA |
| Available In | CB_SD |
| RNA Seq | P1 |
| Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy